Corneal Cross-Linking CXL Approved in the United States by the FDA for Keratoconus and Corneal Ectasia Patients!

The doctors at Slade & Baker Vision are very pleased to announce the FDA approval of Corneal Cross-Linking (CXL) for Keratoconus and Corneal Ectasia.

At Slade & Baker Vision, we have the longest experience with Corneal Cross-Linking in Texas, including the FDA Trials.

Dr. Slade, at the request of Avedro, spoke at the FDA approval meeting in support of CXL.

Our Doctors also started and led the largest FDA trial for CXL, the AECOS Trial with Avedro, right here in Houston!

CXL is an effective treatment Keratoconus, with good safety and minimal discomfort. CXL typically halts the progression of the disease.

We are happy to offer free screenings for any patient who believes they may be a candidate for this procedure.

Please call our clinic in Houston, TX at [mn_location pid=’128′]{tel}[/mn_location] to schedule or ask us any questions about this procedure today!

Please click on THIS LINK to read the full announcement!

Tagged with: , , , , , , , , ,

Posted in: General

Questions? Contact Us Now!

Contact our Office

713-626-7744
3900 Essex Lane – Suite 101
Houston, TX 77027

Get Directions

3900 Essex Lane - Suite 101 - Houston, TX 77027  -  713-626-5544